Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Best of Daniel Loeb’s (Third Point) New Stock Picks

We love Dan Loeb. With an annual alpha of more than 7%, he’s certainly made his mark in the hedge fund circles. And like hedge fund circles, there’s very little literature on his investment style. One of the few sources we found (that we trust) is Katherine Burton’s “Hedge Hunters.”

what is a hedge fund

According to the book, Loeb buys companies with solid franchises that are trading at a discount and that generate a lot of free cash flow. These companies are misjudged by the market, and the situations are more common for entities emerging from bankruptcy.

According to “Hedge Hunters,” Loeb thinks those companies may have a more favorable operating model than in the past, and managers have a greater incentive to make the businesses succeed. He says management may or may not unconsciously understate the performance of the company. The initial goal of the fund was to “invest in special situations in distressed debt and equity, and that’s still how the firm invests today. Loeb seeks out shares to buy, or ones to sell short, which will produce a 30 to 50 percent annualized return.”

Burton says Third Point has a concentrated portfolio. The top ten, she says, account for nearly 50% of its long positions. “Loeb uses a modest amount of leverage, with the portfolio’s gross exposure at 100 to 200 percent of assets and net exposure between 30 percent and 70 percent.” With four partners, he runs industry groups. Teams also focus on geographic areas.  “Another is dedicated to short selling. The partners have discretion to buy or sell short up to a certain position size, and if they think a bet is worthy of a bigger stake, they bring the idea to Loeb. If he agrees, the position can grow as large as 10 percent of assets.”

You can read more about Daniel Loeb’s investment style, his background and his scuffles with company executives and other hedge funds (i.e. Citadel’s Ken Griffin) in Katherine Burton’s “Hedge Hunters”.  

Here are the 20 Largest Stocks in Third Point’s portfolio:

Stock Ticker Value (x1000)
POTASH CORP SASK INC POT             144,040
ALCON INC ACL             116,753
AIRGAS INC ARG             101,925
HEALTH NET INC HNT                76,132
PHH CORP PHH                73,710
CIT GROUP INC CIT                63,271
MEAD JOHNSON NUTRITION CO MJN                56,910
LIBERTY MEDIA CORP NEW LCAPA                54,840
APPLE INC AAPL                42,562
NXP SEMICONDUCTORS N V NXPI                37,790
ASPEN TECHNOLOGY INC AZPN                36,295
DEPOMED INC DEPO                30,419
ORITANI FINL CORP DEL ORIT                20,390
PHH CORP PHH                17,512
CAREFUSION CORP CFN                17,388
XERIUM TECHNOLOGIES INC XRM                17,062
MADISON SQUARE GARDEN INC MSG                16,872
SPDR GOLD TRUST GLD                14,710
NORTHERN TR CORP NTRS                14,472

Insider Monkey, your source for free insider trading data, knows that the stocks recently added to a hedge fund manager’s portfolio are more likely to beat the index funds. We developed a proprietary ranking system that determines which among the newly acquired stocks will perform even better than the rest.

Here are our top five picks among Daniel Loeb’s purchases during the third quarter:


In addition to these, Third Point also bought Six Flags (SIX) which had recent insider purchases. Oneida Financial (ONFC), Northern Trust (NTRS), Eagle Rock Energy Partners (EROC), Gold ETF (GLD), and Apple (AAPL) were all among the recent purchases by Dan Loeb.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!